Rezdiffra leads MASH as TAM expands; growth for 2–3 years but big competition risks. Click for more on MDGL here.

Ages 40 to 65 see a period of turmoil in the brain that has previously been overlooked. But identifying problems during this ...

A new study on artery disease reinforces exactly that idea. Atherosclerosis, the slow buildup of plaque inside the arteries, ...

Pharmaceutical companies have spent years targeting a common blood particle associated with heart-attack risks.

Novel lead small molecules demonstrate substantial reduction of cholesterol accumulation in NPC patient-derived fibroblasts, ...

If your doctor has mentioned fatty liver disease after a recent round of blood tests, take a deep breath—you're in good ...

Hypertension, often dismissed as a common and manageable condition, is quietly becoming one of the Philippines’ most serious ...

Here’s a cooking tip you might be surprised to hear from a nutritionist: Go ahead, embrace shortcuts. Yes, it’s ideal to use ...

Donald Trump's recent medical report is under scrutiny for lacking key cardiac data, raising scepticism among specialists ...

The findings of this study are important because most research on type 2 diabetes focuses on people who are overweight or ...

Cardiologists explain the biggest misconception around heart health, and why waiting for symptoms is "the wrong strategy." ...

A Harvard study found that people who could do more push-ups were less likely to develop heart problems over the next decade.